![]() |
![]() |
![]() |
![]() |
![]() |
|
|
Washington, D.C., September 13, 2004 - A recent study by the Association of American Medical Colleges (AAMC) indicates that U.S. medical schools have made significant progress since 2001 in clarifying and strengthening their financial conflicts of interest (COI) standards in clinical research, with 95 percent now having a policy in place that applies to all human subjects research (HSR). Following the publication in 2001 of the AAMC task force report, "Protecting Subjects, Preserving Trust, Promoting Progress: Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research," the AAMC conducted a survey from May 2003 to February 2004 to assess the degree to which COI policies of the nation's accredited medical schools reflected the recommendations of the task force and responded to the changed circumstances of clinical research. Eighty-two percent of accredited U.S. allopathic medical schools responded to the AAMC survey. Among the key findings:
The AAMC's 2001 COI task force recommended that institutions adopt the presumption that a researcher with a significant financial interest should not be permitted to conduct research on human subjects unless the researcher could demonstrate compelling circumstances to proceed. The survey results indicate that 81 percent of institutions permit a researcher with a significant financial interest to conduct human subjects research when they find that compelling circumstances exist. Despite this substantial progress, the survey results also indicate that certain policies and procedures still need more attention from the academic medicine community. For example:
In addition, many medical school policies do not suggest or require the involvement of patient representatives while recruiting or gaining the consent of human research participants; about half do not conduct regular audits of the consent and enrollment process and do not routinely use special committees established to monitor participants' safety during clinical trials. More consideration should be given to these safeguards to better protect research subjects, according to David Korn, M.D., senior vice president of AAMC's Division of Biomedical and Health Sciences Research. "As calls increase for rapid translation of scientific discoveries into human benefit, the need to ensure that research on human subjects is conducted within an ethical framework that is rigorous, transparent and credible has never been more urgent," said Korn. "While this has been a challenging task for medical schools, and is still a work in progress, our study indicates that significant strides have been made in responding to the public's concerns." To view the COI survey report, go to: www.aamc.org/members/coitf # # # The Association of American Medical Colleges is a not-for-profit association representing all 129 accredited U.S. and 17 accredited Canadian medical schools; nearly 400 major teaching hospitals and health systems, including 68 Department of Veterans Affairs medical centers; and 94 academic and scientific societies. Through these institutions and organizations, the AAMC represents 109,000 faculty members, 67,000 medical students, and 104,000 resident physicians. Additional information about the AAMC and U.S. medical schools and teaching hospitals is available at www.aamc.org/newsroom. |
|||
|
Contact Us © 1995-2008 AAMC Terms and Conditions Privacy Statement |